wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33896738-9730FF56-DAA9-4709-A646-D4E8F36B8D08
Q33896738-9730FF56-DAA9-4709-A646-D4E8F36B8D08
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33896738-9730FF56-DAA9-4709-A646-D4E8F36B8D08
Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicity
P2860
Q33896738-9730FF56-DAA9-4709-A646-D4E8F36B8D08
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33896738-9730FF56-DAA9-4709-A646-D4E8F36B8D08
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b988d9046cc0b39a976b9c5484a60a40f258488c
P2860
Novel designs of multivalent anti-CD20 humanized antibodies as improved lymphoma therapeutics.